entertainment -WSS

entertainment

author：hotspot 2025-10-01 00:05:35 - browse：881

Eli Lilly headquarters — Kristoffer Tripplaar/AP

The drug giant Eli Lilly said Thursday that its diabetes drug Mounjaro helped patients with the condition lose 15.7% of their body weight in a clinical trial, a result that Wall Street analysts expect to pave the way for the therapy’s approval as a weight loss treatment.

Mounjaro is the latest drug in a class known as GLP-1s or incretins — the same class as Novo Nordisk’s Ozempic, which has become a sensation because of its ability to help patients lose weight. Mounjaro has shown the potential to lead to even greater weight loss than Ozempic, and industry experts expect that it will eventually generate many billions of dollars in annual sales. Analysts at SVB Securities projected in December that Mounjaro sales could reach $26.4 billion by 2030.

Eli Lilly on Thursday also announced quarterly earnings of $1.64 per share, adjusted for one-time items, slightly below analyst expectations, on sales of $6.96 billion. Sales were hurt because of a comparison to a year ago, when the company’s Covid-19 monoclonal antibodies were still on the market. Mounjaro sales for the first quarter were $586 million, largely for people with diabetes, compared to an analyst consensus of $433.2 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Bird flu in dairy cattle: New measures to control spread to humans

WSS

Printout prescription drug information shouldn’t go digital

Republican states more likely to report Covid vaccine side effects

Bird flu in dairy cattle: New measures to control spread to humans

Flu vaccine reformulation won't be easy, manufacturers warn

CVS is on a mission to consolidate health care. Will it work?

Republican states more likely to report Covid vaccine side effects

focus

entertainment

focus

DIEP, the 'gold standard' of breast reconstruction, is under threat

Bird flu in dairy cattle: New measures to control spread to humans

Dobbs anniversary: the lost opportunity of abortion as health care

People with mental disorders often marry others with same

After affirmative action ruling, medical educators look to 'holistic review'

Drug companies' payments and gifts affect physicians' prescribing

Virginia high school admissions case could be legal follow

Future doctors need a strong humanities education

Activists slam private health insurers over coverage restrictions

Bird flu in dairy cattle: New measures to control spread to humans

focus

Scientists uncover potential path to treating deadly childhood tumor

Maisha Meds is a PBM, but don't call it that

Scientists uncover potential path to treating deadly childhood tumor

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Drug companies' payments and gifts affect physicians' prescribing

First Opinion on colorectal cancer screening: letter and response

knowledge

focus

Wikipedia

leisure time